NCT06727578 Pleural Irrigation With a Novel Devise.
| NCT ID | NCT06727578 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beth Israel Deaconess Medical Center |
| Condition | Pleural Effusion Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-05-25 |
| Primary Completion | 2027-05-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-05-25 with a primary completion date of 2027-05-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Single-arm pilot trial of the use of intrapleural saline irrigation to treat retained pleural infections for patients with contraindications to standard of care intrapleural enzymatic therapy.
Eligibility Criteria
Inclusion Criteria: * Retained pleural effusion identified via bedside ultrasound within the first 24 hours after chest tube insertion * Patient is contraindicated from receiving intrapleural enzymatic therapy within the first 24 hours after chest tube insertion Exclusion Criteria: * Non-infectious cause of pleural fluid analysis findings listed above identified (e.g. malignancy) * Post-procedural empyema or complicated parapneumonic effusion
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06727578 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pleural Effusion Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06727578 currently recruiting?
Yes, NCT06727578 is actively recruiting participants. Contact the research team at Cconley@bidmc.harvard.edu for enrollment information.
Where is the NCT06727578 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06727578 clinical trial?
NCT06727578 is sponsored by Beth Israel Deaconess Medical Center. The trial plans to enroll 10 participants.